#SFHS2611715VPrice Notice for Eribuline HIKMA in French Hospitals
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This notice sets the reimbursement tariff and maximum pre-tax selling price for Eribuline HIKMA 0.44 mg/ml, 2 ml vial, supplied by Hikma France, at €167.832 per unit for health establishments.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Sets the reimbursement tariff for Eribuline HIKMA at €167.832 per unit.
- Sets the maximum pre-tax selling price to health establishments at €167.832 per unit.
- Applies to the Eribuline HIKMA 0.44 mg/ml, 2 ml vial supplied by Hikma France.
Obligations
What this law requires
Hikma France and entities selling ERIBULINE HIKMA 0.44 mg/ml, 2 ml vial, UCD code 34008 900 565 2 6, to health establishments must apply a maximum pre-tax selling price of €167.832 per UCD.
Health establishments must use €167.832 per UCD as the reimbursement tariff for ERIBULINE HIKMA 0.44 mg/ml, 2 ml vial, UCD code 34008 900 565 2 6.